Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation

Annals of Hematology

Volumn 86, Issue 5, 2007, Pages 339-345

  Łuczyński, Włodzimierz ^a   Kowalczuk, Oksana ^a   Iłendo, Elzbieta ^a   Stasiak Barmuta, Anna ^a   Krawczuk Rybak, Maryna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Acute lymphoblastic leukemia; Antigen processing machinery; Cancer vaccine; CD40L; Dendritic cells; Flow cytometry; Real time PCR

Indexed keywords

B7 ANTIGEN; CALNEXIN; CALRETICULIN; CD40 ANTIGEN; CD40 LIGAND; CD83 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; MESSENGER RNA; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOTHERAPY; CELL CULTURE; CELL STIMULATION; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADOLESCENT; ANTIGEN PRESENTATION; ANTIGENS, CD40; CANCER VACCINES; CD40 LIGAND; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-4; LEUKEMIA, B-CELL, ACUTE; MALE; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33947611105     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0256-z     Document Type: Article

References (29)

1. D'Amico G, Marin V, Biondi A (2004) Potential use of CD40 ligand for immunotherapy of childhood B-cell precursor acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 17:465-477
2. Łuczyłski W, Stasiak-Barmuta A, Iłendo E, Krawczuk-Rybak M, Malinowska I, Mitura-Lesiuk M, Parfieńczyk A, Szymański A (2006) CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. Acta Biochim Pol 53:377-382
3. D'Amico G, Vulcano M, Bugarin C, Bianchi G, Pirovano G, Bonamino M, Marin V, Allavena P, Biagi E, Biondi A (2004) CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12 defective APCs that induce allogeneic T-cell anergy. Blood 104:744-751
4. Łuczyński W, Iłendo E, Kovalchuk O, Krawczuk-Rybak M, Malinowska I, Kołtan A, Szczepański T, Wysocka J, Jaworowski R, Olejnik I, Chyczewski L, Matysiak M, Wysocki M, Sońta-Jakimczyk D, Wieczorek M (2006) Acute lymphoblastic leukemia cells express CCR7 but not higher amounts of IL-10 after CD40 ligation. Scand J Clin Lab Invest 66:695-704
5. Abele R, Tampe R (2006) Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 580:1156-1163
6. Ritz U, Momburg F, Pilch H, Huber C, Maeurer MJ, Seliger B (2001) Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. Int J Oncol 19:1211-1220
7. Atkins D, Ferrone S, Schmahl GE, Storkel S, Seliger B (2004) Down-regulation of HLA class I antigen processing molecules: An immune escape mechanism of renal cell carcinoma? J Urol 171:885-889
8. Romero JM, Jimenez P, Cabrera T, Cozar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F (2005) Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int J Cancer 113:605-610
9. Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M, Campoli M, Ferrone S (2005) Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res 11:8304-8311
10. Frisan T, Zhang QJ, Levitskaya J, Coram M, Kurilla MG, Masucci MG (1996) Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. Int J Cancer 68:251-258
11. Dutta N, Gupta A, Mazumder DN, Banerjee S (2006) Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: Implication for viral-induced immune evasion. Cancer 106:1685-1693
12. Ressing ME, Keating SE, van Leeuwen D, Koppers-Lalic D, Pappworth IY, Wiertz EJ, Rowe M (2005) Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J Immunol 174:6829-6838
13. Claus JA, Brady MT, Lee J, Donohue KA, Sait SN, Ferrone S, Wetzler M (2006) T-cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic cells is associated with increased tapasin expression. Cancer Immunol Immunotheras 55:160-165
14. Ghia P, Transdico P, Veiga JP, Schaniel C, Sallusto F, Matsushima K, Sallan SE, Rolink AG, Mantovani A, Nadler LM, Cardoso AA (2001) Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. Blood 98:533-540
15. Seliger B, Schreiber K, Delp K, Meissner M, Hammers S, Reichert T, Pawlischko K, Tampe R, Huber C (2001) Downregulation of the constitutive tapasin expression on human tumor cells of distinct origin and its transcriptional upregulation by cytokines. Tissue Antigens 57:39-45
16. Whiteside TL, Stanson J, Shurin MR, Ferrone S (2004) Antigen-processing machinery in human dendritic cells: Up-regulation by maturation and down-regulation by tumor cells. J Immunol 173:1526-1534
17. Tourkova IL, Shurin GV, Chatta GS, Perez L, Finke J, Whiteside TL, Ferrone S, Shurin MR (2005) Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides. J Immunol 175:3045-3052
18. Raffaghello L, Prigione I, Bocca P, Morandi F, Camoriano M, Gambini C, Wang X, Ferrone S, Pistoia V (2005) Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene 24:4634-4644
19. Satoh E, Mabuchi T, Satoh H, Asahara T, Nukui H, Naganuma H (2006) Reduced expression of the transporter associated with antigen processing 1 molecule in malignant glioma cells, and its restoration by interferon-gamma and -beta. J Neurosurg 104:264-271
20. Lopez-Albaitero A, Nayak JV, Ogino T, Machandia A, Gooding W, de Leo AB, Ferrone S, Ferris RL (2006) Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL. J Immunol 176:3402-3409
21. Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, Choi KB, Jeffries AP, Elliott WM, Atkins D, Seliger B, Jefferies WA (2005) Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res 65:7926-7933
22. Alimonti J, Zhang QJ, Gabathuler R, Reid G, Chen SS, Jefferies WA (2000) TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat Biotechnol 18:515-520
23. Lin CT, Chang TC, Chao A, Dzeng E, Soong YK, Hung CF, Lai CH (2005) Enhancement of DNA vaccine potency through linkage of antigen gene to ER chaperone molecules, ER-60, tapasin, and calnexin. J Biomed Sci 12:279-287
24. Yang T, Lapinski PE, Zhao H, Zhou Q, Zhang H, Raghavan M, Liu Y, Zheng P (2005) A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing. Clin Cancer Res 11:3614-3623
25. Agrawal S, Reemtsma K, Bagiella E, Oluwole SF, Braunstein NS (2004) Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma. Cell Immunol 228:130-137
26. Norbury CC, Princiotta MF, Bacik I, Brutkiewicz RR, Wood P, Elliott T, Bennink JR, Yewdell JW (2001) Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J Immunol 166:4355-4362
27. Dissanayake SK, Tuera N, Ostrand-Rosenberg S (2005) Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome. J Immunol 174:1811-1819
28. van Hall T, Wolpert EZ, van Veelen P, Laban S, van der Veer M, Roseboom M, Bres S, Grufman P, de Ru A, Meiring H, deJong A, Franken K, Teixeira A, Valentijn R, Drijfhout JW, Konig F, Camps M, Ossendorp F, Karre K, Ljunggren HG, Melief CJ, Offringa R (2006) Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 12:417-424
29. Turnquist HR, Kohlgraf KG, McIlhaney MM, Mosley RL, Hollingsworth MA, Solheim JC (2004) Tapasin decreases immune responsiveness to a model tumor antigen. J Clin Immunol 24:462-470